S&P 500   4,516.57 (-1.32%)
DOW   34,422.88 (-0.63%)
QQQ   380.67 (-2.37%)
AAPL   160.30 (-2.11%)
MSFT   318.86 (-3.23%)
FB   304.73 (-1.82%)
GOOGL   2,821.66 (-1.32%)
AMZN   3,366.58 (-2.06%)
TSLA   1,022.14 (-5.76%)
NVDA   304.41 (-5.24%)
BABA   112.88 (-7.48%)
NIO   31.86 (-11.99%)
CGC   10.04 (-3.09%)
AMD   142.63 (-5.34%)
GE   92.49 (-2.88%)
MU   80.91 (-2.38%)
T   23.44 (+1.69%)
F   19.15 (-3.62%)
DIS   145.13 (-1.41%)
PFE   54.07 (+1.94%)
AMC   27.16 (-10.30%)
ACB   5.80 (-5.54%)
BA   196.96 (-2.68%)
S&P 500   4,516.57 (-1.32%)
DOW   34,422.88 (-0.63%)
QQQ   380.67 (-2.37%)
AAPL   160.30 (-2.11%)
MSFT   318.86 (-3.23%)
FB   304.73 (-1.82%)
GOOGL   2,821.66 (-1.32%)
AMZN   3,366.58 (-2.06%)
TSLA   1,022.14 (-5.76%)
NVDA   304.41 (-5.24%)
BABA   112.88 (-7.48%)
NIO   31.86 (-11.99%)
CGC   10.04 (-3.09%)
AMD   142.63 (-5.34%)
GE   92.49 (-2.88%)
MU   80.91 (-2.38%)
T   23.44 (+1.69%)
F   19.15 (-3.62%)
DIS   145.13 (-1.41%)
PFE   54.07 (+1.94%)
AMC   27.16 (-10.30%)
ACB   5.80 (-5.54%)
BA   196.96 (-2.68%)
S&P 500   4,516.57 (-1.32%)
DOW   34,422.88 (-0.63%)
QQQ   380.67 (-2.37%)
AAPL   160.30 (-2.11%)
MSFT   318.86 (-3.23%)
FB   304.73 (-1.82%)
GOOGL   2,821.66 (-1.32%)
AMZN   3,366.58 (-2.06%)
TSLA   1,022.14 (-5.76%)
NVDA   304.41 (-5.24%)
BABA   112.88 (-7.48%)
NIO   31.86 (-11.99%)
CGC   10.04 (-3.09%)
AMD   142.63 (-5.34%)
GE   92.49 (-2.88%)
MU   80.91 (-2.38%)
T   23.44 (+1.69%)
F   19.15 (-3.62%)
DIS   145.13 (-1.41%)
PFE   54.07 (+1.94%)
AMC   27.16 (-10.30%)
ACB   5.80 (-5.54%)
BA   196.96 (-2.68%)
S&P 500   4,516.57 (-1.32%)
DOW   34,422.88 (-0.63%)
QQQ   380.67 (-2.37%)
AAPL   160.30 (-2.11%)
MSFT   318.86 (-3.23%)
FB   304.73 (-1.82%)
GOOGL   2,821.66 (-1.32%)
AMZN   3,366.58 (-2.06%)
TSLA   1,022.14 (-5.76%)
NVDA   304.41 (-5.24%)
BABA   112.88 (-7.48%)
NIO   31.86 (-11.99%)
CGC   10.04 (-3.09%)
AMD   142.63 (-5.34%)
GE   92.49 (-2.88%)
MU   80.91 (-2.38%)
T   23.44 (+1.69%)
F   19.15 (-3.62%)
DIS   145.13 (-1.41%)
PFE   54.07 (+1.94%)
AMC   27.16 (-10.30%)
ACB   5.80 (-5.54%)
BA   196.96 (-2.68%)
NASDAQ:MOTS

Motus GI Stock Forecast, Price & News

$0.42
-0.03 (-7.07%)
(As of 12/3/2021 01:17 PM ET)
Add
Compare
Today's Range
$0.42
$0.45
50-Day Range
$0.45
$0.78
52-Week Range
$0.43
$2.74
Volume
14,600 shs
Average Volume
2.29 million shs
Market Capitalization
$20.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.43
30 days | 90 days | 365 days | Advanced Chart
Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.


Motus GI logo

About Motus GI

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in September, 2016 and is headquartered in Fort Lauderdale, FL.

Headlines

Critical Analysis: Motus GI (NASDAQ:MOTS) & Medifocus (OTCMKTS:MDFZF)
November 29, 2021 |  americanbankingnews.com
Is Motus GI Holdings (NASDAQ:MOTS) A Risky Investment?
November 15, 2021 |  finance.yahoo.com
Motus GI (NASDAQ:MOTS) Rating Reiterated by HC Wainwright
November 15, 2021 |  americanbankingnews.com
Motus GI Hldgs Earnings Preview
November 11, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MOTS
Employees
24
Year Founded
N/A

Sales & Book Value

Annual Sales
$100 thousand
Book Value
$0.35 per share

Profitability

Net Income
$-19.26 million
Net Margins
-5,675.00%
Pretax Margin
-5,674.69%

Debt

Price-To-Earnings

Miscellaneous

Free Float
44,965,000
Market Cap
$20.42 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/12/2021
Today
12/03/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
3/15/2022

MarketRank

Overall MarketRank

2.06 out of 5 stars

Medical Sector

542nd out of 1,391 stocks

Surgical & Medical Instruments Industry

54th out of 126 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Motus GI (NASDAQ:MOTS) Frequently Asked Questions

Is Motus GI a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Motus GI stock.
View analyst ratings for Motus GI
or view top-rated stocks.

How has Motus GI's stock been impacted by Coronavirus?

Motus GI's stock was trading at $1.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MOTS stock has decreased by 59.3% and is now trading at $0.4230.
View which stocks have been most impacted by COVID-19
.

When is Motus GI's next earnings date?

Motus GI is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022.
View our earnings forecast for Motus GI
.

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) announced its quarterly earnings data on Friday, November, 12th. The company reported ($0.10) EPS for the quarter, hitting analysts' consensus estimates of ($0.10). Motus GI had a negative net margin of 5,675.00% and a negative trailing twelve-month return on equity of 78.81%. During the same period last year, the firm earned ($0.13) earnings per share.
View Motus GI's earnings history
.

What price target have analysts set for MOTS?

3 analysts have issued twelve-month target prices for Motus GI's shares. Their forecasts range from $1.50 to $2.05. On average, they expect Motus GI's share price to reach $1.85 in the next year. This suggests a possible upside of 337.4% from the stock's current price.
View analysts' price targets for Motus GI
or view top-rated stocks among Wall Street analysts.

Who are Motus GI's key executives?

Motus GI's management team includes the following people:
  • Timothy P. Moran, Chief Executive Officer & Director
  • Mark Pomeranz, President, Chief Operating Officer & Director
  • Andrew L. Taylor, Chief Financial Officer
  • Ravit Ram, Vice President-Operations & Site Manager Israel
  • Jeff Hutchison, Vice President-U.S. Sales & Commercial Operations

What other stocks do shareholders of Motus GI own?

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

Who are Motus GI's major shareholders?

Motus GI's stock is owned by many different institutional and retail investors. Top institutional shareholders include Oracle Investment Management Inc. (6.11%), BlackRock Inc. (0.42%) and Millennium Management LLC (0.25%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Larry N Feinberg, Mark Pomeranz, Perceptive Advisors Llc and Timothy P Moran.
View institutional ownership trends for Motus GI
.

Which major investors are selling Motus GI stock?

MOTS stock was sold by a variety of institutional investors in the last quarter, including Oracle Investment Management Inc.. Company insiders that have sold Motus GI company stock in the last year include Larry N Feinberg, and Perceptive Advisors Llc.
View insider buying and selling activity for Motus GI
or view top insider-selling stocks.

Which major investors are buying Motus GI stock?

MOTS stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., and Millennium Management LLC. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Mark Pomeranz, and Timothy P Moran.
View insider buying and selling activity for Motus GI
or or view top insider-buying stocks.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $0.42.

How much money does Motus GI make?

Motus GI has a market capitalization of $20.42 million and generates $100 thousand in revenue each year. The company earns $-19.26 million in net income (profit) each year or ($0.57) on an earnings per share basis.

How many employees does Motus GI have?

Motus GI employs 24 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is www.motusgi.com.

Where are Motus GI's headquarters?

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at (954) 541-8000, via email at [email protected], or via fax at 954-541-8265.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.